-
241
PRL2 inhibition elevates PTEN protein and ameliorates progression of acute myeloid leukemia
Published 2023-10-01Subjects: Get full text
Article -
242
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells
Published 2022-08-01Subjects: Get full text
Article -
243
Highly synchronized cortical circuit dynamics mediate spontaneous pain in mice
Published 2023-03-01Subjects: Get full text
Article -
244
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Published 2022-11-01Subjects: Get full text
Article -
245
Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice
Published 2021-10-01Subjects: Get full text
Article -
246
Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
Published 2023-11-01Subjects: Get full text
Article -
247
Preclinical testing of dabigatran in trypsin-dependent pancreatitis
Published 2022-11-01Subjects: Get full text
Article -
248
From pathogenesis to current treatment of the cutaneous psoriasis - a literature review
Published 2023-12-01Subjects: Get full text
Article -
249
Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
Published 2023-10-01Subjects: “…Therapeutics…”
Get full text
Article -
250
A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
Published 2022-11-01Subjects: Get full text
Article -
251
Phenylbutyrate modulates polyamine acetylase and ameliorates Snyder-Robinson syndrome in a Drosophila model and patient cells
Published 2022-07-01Subjects: Get full text
Article -
252
Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice
Published 2022-12-01Subjects: Get full text
Article -
253
BCL6 is regulated by the MAPK/ELK1 axis and promotes KRAS-driven lung cancer
Published 2022-11-01Subjects: Get full text
Article -
254
Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove
Published 2023-02-01Subjects: Get full text
Article -
255
Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis
Published 2022-03-01Subjects: Get full text
Article -
256
Cell-free and alkylated hemoproteins improve survival in mouse models of carbon monoxide poisoning
Published 2022-11-01Subjects: Get full text
Article -
257
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis
Published 2023-10-01Subjects: Get full text
Article -
258
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma
Published 2023-02-01Subjects: Get full text
Article -
259
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion
Published 2022-08-01Subjects: Get full text
Article -
260
Targeting Gi/o protein–coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy
Published 2021-09-01Subjects: Get full text
Article